Barclays’s SYNERGETICS USA, INC. SURG Stock Holding History

Barclays’s Portfolio SURG Stock Details SURG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,200	Closed	-$31K	–	7221
2015 Q3	$31K	Buy	+5,200	New	+$27K	﹤0.01%	5274
2014 Q2	–	Sell	-1,600	Closed	-$5K	–	7983
2014 Q1	$5K	Buy	+1,600	New	+$5.42K	﹤0.01%	7238

Barclays's SURG Position: Q4 2015 in Review

Barclays sold out of SYNERGETICS USA, INC. (SURG) in Q4 2015, closing a stake of 5,200 shares — an estimated $31K sold.

Barclays first reported a position in SURG in Q1 2014 and held it in 2 quarters. The position peaked at $31K in Q3 2015. 0 funds tracked by Wall St. Rank hold SURG as of Q4 2015.

Barclays reported no remaining SYNERGETICS USA, INC. position as of Q4 2015 after selling out during the quarter.
Barclays sold 5,200 SYNERGETICS USA, INC. shares in Q4 2015, an estimated $31K.
Barclays first reported a position in SYNERGETICS USA, INC. in Q1 2014 and held it in 2 quarters.
Barclays's SYNERGETICS USA, INC. position peaked at $31K in Q3 2015.
0 funds tracked by Wall St. Rank held SYNERGETICS USA, INC. as of Q4 2015.

Based on Barclays's 13F filing for Q4 2015, filed 12 Feb 2016.